Verrica Pharmaceuticals Inc.

Healthcare

NASDAQ:VRCA · NASDAQ Global Market

Market Cap $62.53M Beta 1.49 P/E (TTM) -3.4

$5.73 -4.90%

-$0.30 today

52W Low $3.28High $9.82

Vol 0.05M · Avg 0.09M

EPS (TTM)-$1.67

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-8.03%

Period High

$9.10

Period Low

$3.28

Latest

$5.73

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Q32 Bio Inc.

NASDAQ:QTTB

$161.49M

AN2 Therapeutics, Inc.

NASDAQ:ANTX

$129.89M

Generation Bio Co.

GBIO

$35.98M

Mural Oncology plc

MURA

$35.38M

SAB Biotherapeutics, Inc.

SABS

$31.83M

Boundless Bio, Inc.

BOLD

$31.67M

Evaxion Biotech A/S

EVAX

$22.99M

Plus Therapeutics, Inc.

PSTV

$12.12M

Jasper Therapeutics, Inc.

JSPR

$7.44M

NextCure, Inc.

NXTC

$5.56M

What is the latest VRCA filing?

The latest filing shown is 4 dated Jun 9, 2026.

How many recent filings does VRCA have?

Intrinsic Alpha currently shows 20 recent filings for VRCA.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.